351.3500 -7.45 (-2.08%)
NSE Mar 20, 2026 15:31 PM
Volume: 414.1K
 

ICICI Securities Limited
Thyrocare’s Q2FY24 performance was in line with our expectations. Its revenue grew 9.7% YoY while the franchisee business grew faster at 20%. It reported an improvement in gross margins (+100bps YoY) due to a decline in the lowmargin Partnership business.
Promoters pledged 14.16% of shares in last quarter. Total pledge stands at 100.00% of promoter holdings
More from Thyrocare Technologies Ltd.
Recommended